EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Randomisierte kontrollierte StudieOpen Access

Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15

Shizuya Yamashita, Arihiro Kiyosue, Pierre Maheux, Jorge Mena-Madrazo, Anastasia Lesogor, Qing Shao, Yuko Tamaki, Hidekazu Nakamura, Mizuki Akahori, Kouji Kajinami

Journal of Atherosclerosis and Thrombosis · 01.06.2024 · 31 (6) · 876-903

DOI: 10.5551/jat.64454 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.06.2024. Verfasst von Shizuya Yamashita und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Rinku General Medical Center. Hauptthemen laut MEDLINE: Cholesterol, LDL, Hypercholesterolemia. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholesterol, LDLHypercholesterolemiaAgedFemaleHumansMaleMiddle AgedDouble-Blind MethodEast Asian PeopleHyperlipoproteinemia Type IIJapanProprotein Convertase 9RNA, Small InterferingTreatment Outcome

Stichwörter der Autor:innen

Familial hypercholesterolemiaInclisiranLow-density lipoprotein cholesterolPCSK9Pharmacokinetics

Substanzen

ALN-PCSCholesterol, LDLPCSK9 protein, humanProprotein Convertase 9RNA, Small Interfering

Autor:innen und Institutionen

  • Department of Cardiology, Rinku General Medical Center.
  • Tokyo-Eki Center-building Clinic.
  • Novartis Pharma AG.
  • Novartis Pharmaceuticals Corporation.
  • Novartis Pharma K.K.
  • Kanazawa Medical University.

Zitieren

APA

Yamashita, S., Kiyosue, A., Maheux, P., Mena-Madrazo, J., Lesogor, A., Shao, Q., Tamaki, Y., Nakamura, H., Akahori, M., & Kajinami, K. (2024). Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15. Journal of Atherosclerosis and Thrombosis, 31(6), 876-903. https://doi.org/10.5551/jat.64454

Vancouver

Yamashita S, Kiyosue A, Maheux P, Mena-Madrazo J, Lesogor A, Shao Q, et al. Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15. Journal of Atherosclerosis and Thrombosis. 2024;31(6):876-903. doi:10.5551/jat.64454

BibTeX
@article{Yamashita2024,
  author = {Yamashita, Shizuya and Kiyosue, Arihiro and Maheux, Pierre and Mena-Madrazo, Jorge and Lesogor, Anastasia and Shao, Qing and Tamaki, Yuko and Nakamura, Hidekazu and Akahori, Mizuki and Kajinami, Kouji},
  title = {Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2024},
  volume = {31},
  number = {6},
  pages = {876--903},
  doi = {10.5551/jat.64454}
}
Kostenlos starten →